NCT04757675View on ClinicalTrials.gov

S-ketamin Premedication in Pediatric EENT Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

January 1, 2022

Conditions
EmotionsSeparation AnxietyPain, Procedural
Interventions
DRUG

S-ketamine 0.3

0.3 μg/kg intravenous injection s-ketamin

DRUG

S-ketamine 0.5

0.5 μg/kg intravenous injection s-ketamin

DRUG

S-ketamine 2

2 μg/kg intranasal s-ketamin

DRUG

S-ketamine 1+Dexmedetomidine 1

1 μg/kg intranasal s-ketamin + 1 μg/kg intranasal dexmedetomidine

DRUG

S-ketamine 0.5 +Dexmedetomidine 2

0.5 μg/kg intranasal s-ketamin + 2 μg/kg intranasal dexmedetomidine

Trial Locations (1)

Unknown

Eye and ENT Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Eye & ENT Hospital of Fudan University

OTHER

NCT04757675 - S-ketamin Premedication in Pediatric EENT Surgery | Biotech Hunter | Biotech Hunter